3D Body Mapping Helps Repair Cellular Damage
By HospiMedica International staff writers Posted on 02 Jul 2019 |
Image: A floating 3D scaffold providing efficient tissue engineering monitoring (Photo courtesy of ACS Nano).
A new study reveals an innovative three-dimensional (3D) instrumented mapping technology that can monitor and track the behavior of engineered cells and tissues.
Developed by researchers at Purdue University (Lafayette, IN, USA) and Hanyang University (Seoul, Republic of Korea), the ultrabuoyant 3D scaffold remains afloat on the surface of a culture medium, providing a favorable environment for the electronic components, which remain in the air while the cells reside and grow underneath. This enables high-fidelity recording of electrical cell–substrate impedance and electrophysiological signals over long periods of time, even weeks. Currently, long-term reliable 3D monitoring is limited by the wet cell culture conditions, which are unfavorable to electronic instrument settings.
The new scaffold, on the other hand, can provide real-time monitoring of the cellular behaviors and functions, thus providing a profound impact on underlying biophysics and disease modeling. A battery of comprehensive in-vitro studies undertaken by the researchers revealed the utility of the platform as an effective tool for drug screening and tissue development following cancer treatments. They are now testing the potential of the device in stem cell therapies and the regenerative treatment of diseases. The study was published in the June 19, 2019, issue of ACS Nano.
“Tissue engineering already provides new hope for hard-to-treat disorders, and our technology brings even more possibilities. My hope is to help millions of people in need,” said senior author biomedical and mechanical engineer Chi Hwan Lee, PhD, of the Purdue College of Engineering. “This device offers an expanded set of potential options to monitor cell and tissue function after surgical transplants in diseased or damaged bodies.”
Tissue engineering, often called regenerative medicine, combines cell cultures, engineering and materials methods, and biochemical and physicochemical factors to improve or replace biological tissues. It involves the use of a tissue scaffold for the formation of new viable tissue for a medical purpose. While it was once categorized as a sub-field of biomaterials, having grown in scope and importance it can be considered as a field in its own.
Related Links:
Purdue University
Hanyang University
Developed by researchers at Purdue University (Lafayette, IN, USA) and Hanyang University (Seoul, Republic of Korea), the ultrabuoyant 3D scaffold remains afloat on the surface of a culture medium, providing a favorable environment for the electronic components, which remain in the air while the cells reside and grow underneath. This enables high-fidelity recording of electrical cell–substrate impedance and electrophysiological signals over long periods of time, even weeks. Currently, long-term reliable 3D monitoring is limited by the wet cell culture conditions, which are unfavorable to electronic instrument settings.
The new scaffold, on the other hand, can provide real-time monitoring of the cellular behaviors and functions, thus providing a profound impact on underlying biophysics and disease modeling. A battery of comprehensive in-vitro studies undertaken by the researchers revealed the utility of the platform as an effective tool for drug screening and tissue development following cancer treatments. They are now testing the potential of the device in stem cell therapies and the regenerative treatment of diseases. The study was published in the June 19, 2019, issue of ACS Nano.
“Tissue engineering already provides new hope for hard-to-treat disorders, and our technology brings even more possibilities. My hope is to help millions of people in need,” said senior author biomedical and mechanical engineer Chi Hwan Lee, PhD, of the Purdue College of Engineering. “This device offers an expanded set of potential options to monitor cell and tissue function after surgical transplants in diseased or damaged bodies.”
Tissue engineering, often called regenerative medicine, combines cell cultures, engineering and materials methods, and biochemical and physicochemical factors to improve or replace biological tissues. It involves the use of a tissue scaffold for the formation of new viable tissue for a medical purpose. While it was once categorized as a sub-field of biomaterials, having grown in scope and importance it can be considered as a field in its own.
Related Links:
Purdue University
Hanyang University
Latest Health IT News
- Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients
- Strategic Collaboration to Develop and Integrate Generative AI into Healthcare
- AI-Enabled Operating Rooms Solution Helps Hospitals Maximize Utilization and Unlock Capacity
- AI Predicts Pancreatic Cancer Three Years before Diagnosis from Patients’ Medical Records
- First Fully Autonomous Generative AI Personalized Medical Authorizations System Reduces Care Delay
- Electronic Health Records May Be Key to Improving Patient Care, Study Finds
- AI Trained for Specific Vocal Biomarkers Could Accurately Predict Coronary Artery Disease
- First-Ever AI Test for Early Diagnosis of Alzheimer’s to Be Expanded to Diagnosis of Parkinson’s Disease
- New Self-Learning AI-Based Algorithm Reads Electrocardiograms to Spot Unseen Signs of Heart Failure
- Autonomous Robot Performs COVID-19 Nasal Swab Tests
- Statistical Tool Predicts COVID-19 Peaks Worldwide
- Wireless-Controlled Soft Neural Implant Stimulates Brain Cells
- Tiny Polymer Stent Could Treat Pediatric Urethral Strictures
- Human Torso Simulator Helps Design Brace Innovations
- 3D Bioprinting Rebuilds the Human Heart